171 related articles for article (PubMed ID: 25529742)
1. Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives.
Zhang H; Zhu P; Liu J; Lin Y; Yao H; Jiang J; Ye W; Wu X; Xu J
Bioorg Med Chem Lett; 2015 Feb; 25(3):728-32. PubMed ID: 25529742
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives.
Zhang H; Zhu P; Liu J; Yang X; Xu S; Yao H; Jiang J; Ye W; Wu X; Xu J
Eur J Med Chem; 2014 Nov; 87():159-67. PubMed ID: 25247772
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of Oxygen-containing Heterocyclic Ring-fused 23-Hydroxybetulinic Acid Derivatives as Antitumor Agents.
Zhang H; Li F; Zhu P; Liu J; Yao H; Jiang J; Ye W; Wu X; Xu J
Chem Biol Drug Des; 2015 Oct; 86(4):424-31. PubMed ID: 25688519
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and antitumor activity of triterpenoid pyrazine derivatives from 23-hydroxybetulinic acid.
Zhang H; Wang Y; Zhu P; Liu J; Xu S; Yao H; Jiang J; Ye W; Wu X; Xu J
Eur J Med Chem; 2015 Jun; 97():235-44. PubMed ID: 25984840
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
[TBL] [Abstract][Full Text] [Related]
7. Novel pyrazole-5-carboxamide and pyrazole-pyrimidine derivatives: synthesis and anticancer activity.
Shi JB; Tang WJ; Qi XB; Li R; Liu XH
Eur J Med Chem; 2015 Jan; 90():889-96. PubMed ID: 25554922
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and mechanism studies of C-23 modified 23-hydroxybetulinic acid derivatives as anticancer agents.
Lu L; Zhang H; Liu J; Liu Y; Wang Y; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2019 Nov; 182():111659. PubMed ID: 31491611
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of 28-amide derivatives of 23-hydroxy betulinic Acid as antitumor agent candidates.
Bi Y; Xu J; Sun F; Wu X; Ye W; Sun Y; Huang W
Med Chem; 2013 Nov; 9(7):920-5. PubMed ID: 23083117
[TBL] [Abstract][Full Text] [Related]
10. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of 23-hydroxybetulinic acid C-28 ester derivatives as antitumor agent candidates.
Bi Y; Xu J; Sun F; Wu X; Ye W; Sun Y; Huang W
Molecules; 2012 Jul; 17(8):8832-41. PubMed ID: 22832884
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of quinopimaric and maleopimaric acids’ derivatives.
Tretyakova EV; Smirnova IE; Kazakova OB; Tolstikov GA; Yavorskaya NP; Golubeva IS; Pugacheva RB; Apryshko GN; Poroikov VV
Bioorg Med Chem; 2014 Nov; 22(22):6481-9. PubMed ID: 25440729
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents.
Farag AM; Ali KA; El-Debss TM; Mayhoub AS; Amr AG; Abdel-Hafez NA; Abdulla MM
Eur J Med Chem; 2010 Dec; 45(12):5887-98. PubMed ID: 20950898
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and preliminary mechanistic evaluation of 5-(p-tolyl)-1-(quinolin-2-yl)pyrazole-3-carboxylic acid amides with potent antiproliferative activity on human cancer cell lines.
Cankara Pirol Ş; Çalışkan B; Durmaz I; Atalay R; Banoglu E
Eur J Med Chem; 2014 Nov; 87():140-9. PubMed ID: 25247770
[TBL] [Abstract][Full Text] [Related]
15. New imidazo[1,2-b]pyrazoles as anticancer agents: synthesis, biological evaluation and structure activity relationship analysis.
Grosse S; Mathieu V; Pillard C; Massip S; Marchivie M; Jarry C; Bernard P; Kiss R; Guillaumet G
Eur J Med Chem; 2014 Sep; 84():718-30. PubMed ID: 25064349
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line.
El-Gamal MI; Choi HS; Cho HG; Hong JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Nov; 344(11):745-54. PubMed ID: 21954060
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and bioactivities of novel pyrazole and triazole derivatives containing 5-phenyl-2-furan.
Cui ZN; Shi YX; Cui JR; Ling Y; Li BJ; Yang XL
Chem Biol Drug Des; 2012 Jan; 79(1):121-7. PubMed ID: 22023821
[TBL] [Abstract][Full Text] [Related]
18. Development of novel bis-pyrazole derivatives as antitumor agents with potent apoptosis induction effects and DNA damage.
Dai H; Ge S; Guo J; Chen S; Huang M; Yang J; Sun S; Ling Y; Shi Y
Eur J Med Chem; 2018 Jan; 143():1066-1076. PubMed ID: 29232583
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic activity of betulinic acid derivatives on murine melanoma B16 cell line.
Liu WK; Ho JC; Cheung FW; Liu BP; Ye WC; Che CT
Eur J Pharmacol; 2004 Sep; 498(1-3):71-8. PubMed ID: 15363977
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Biological Evaluation of Novel Ursolic acid Derivatives as Potential Anticancer Prodrugs.
Yang X; Li Y; Jiang W; Ou M; Chen Y; Xu Y; Wu Q; Zheng Q; Wu F; Wang L; Zou W; Zhang YJ; Shao J
Chem Biol Drug Des; 2015 Dec; 86(6):1397-404. PubMed ID: 26077799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
